Clinical Trial

Testing Experimental Medication

Study Description

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

The goal of this study is to investigate the safety of [68Ga]CBP8 and its efficacy to detect collagen deposition in pulmonary fibrosis.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - [68Ga]CBP8

Up to 15 mCi of [68Ga]CBP8 will be administered to each subject.

Diagnostic Test - PET Imaging

All subjects will undergo PET imaging after administration of [68Ga]CBP8.

Additional Information

Official Study Title

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer Patients Undergoing Radiation Therapy Prior to the Resection of Locally Advanced Tumors, and Idiopathic Pulmonary Fibrosis Patients

Clinical Trial ID

NCT03535545

ParticipAid ID

9avX8d